Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Copper radiopharmaceuticals for theranostic applications.
Ahmedova A, Todorov B, Burdzhiev N, Goze C. Ahmedova A, et al. Among authors: todorov b. Eur J Med Chem. 2018 Sep 5;157:1406-1425. doi: 10.1016/j.ejmech.2018.08.051. Epub 2018 Aug 23. Eur J Med Chem. 2018. PMID: 30282317 Review.
Synthesis and biological evaluation of novel (123)I-labeled 4-(4-iodophenyl)butanoyl-L-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo.
Kallinen A, Todorov B, Kallionpää R, Bäck S, Sarparanta M, Raki M, García-Horsman JA, Bergström KA, Wallén EA, Männistö PT, Airaksinen AJ. Kallinen A, et al. Among authors: todorov b. Eur J Med Chem. 2014 May 22;79:436-45. doi: 10.1016/j.ejmech.2014.04.014. Epub 2014 Apr 12. Eur J Med Chem. 2014. PMID: 24763264
Sediment Assessment of the Pchelina Reservoir, Bulgaria.
Venelinov T, Mihaylova V, Peycheva R, Todorov M, Yotova G, Todorov B, Lyubomirova V, Tsakovski S. Venelinov T, et al. Among authors: todorov b. Molecules. 2021 Dec 11;26(24):7517. doi: 10.3390/molecules26247517. Molecules. 2021. PMID: 34946602 Free PMC article.
A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: Stage 2 of a phase II trial.
Verstovsek S, Talpaz M, Wadleigh M, Isidori A, Te Boekhorst P, Savona MR, Bose P, Pozdnyakova O, Mesa R, El-Galaly TC, O'Sullivan J, Gamel K, Higgins B, Katakam S, Todorov B, Trunzer K, Harrison CN. Verstovsek S, et al. Among authors: todorov b. Haematologica. 2024 Jan 25. doi: 10.3324/haematol.2023.284410. Online ahead of print. Haematologica. 2024. PMID: 38268448 Free article.
Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.
Verstovsek S, Foltz L, Gupta V, Hasserjian R, Manshouri T, Mascarenhas J, Mesa R, Pozdnyakova O, Ritchie E, Veletic I, Gamel K, Hamidi H, Han L, Higgins B, Trunzer K, Uguen M, Wang D, El-Galaly TC, Todorov B, Gotlib J. Verstovsek S, et al. Among authors: todorov b. Haematologica. 2023 Oct 1;108(10):2730-2742. doi: 10.3324/haematol.2022.282411. Haematologica. 2023. PMID: 37165840 Free PMC article. Clinical Trial.
CaV2.1 channel mutations causing familial hemiplegic migraine type 1 increase the susceptibility for cortical spreading depolarizations and seizures and worsen outcome after experimental traumatic brain injury.
Terpolilli NA, Dolp R, Waehner K, Schwarzmaier SM, Rumbler E, Todorov B, Ferrari MD, van den Maagdenberg AMJM, Plesnila N. Terpolilli NA, et al. Among authors: todorov b. Elife. 2022 Mar 3;11:e74923. doi: 10.7554/eLife.74923. Elife. 2022. PMID: 35238776 Free PMC article.
67 results